BIOCEV awarded for a significant achievement in the field of investment
The award was accepted by prof. Jiří Neužil for the development of the anticancer substance MitoTam, which targets the mitochondria of tumor cells.
"We want to save lives with the help of top research. This award also belongs to my team," said professor Neužil, head of the Laboratory of Molecular Therapy (Institute of Biotechnology AS CR).
The event took place on the occasion of the annual conference of the Association for Foreign Investments (AFI), whose purpose is to provide comprehensive support for investments and investors in the Czech Republic. The AFI was established in 1996 at the instigation of the Czech government (Ministry of Industry and Trade and CzechInvest) as a platform for cooperation between the public and private sectors with the objective of continuously improving the Czech investment environment, the conditions for investors, legislation, communication and exchange of information.